Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

MTA Ancillary Agreement: Sanford-Burnham Medical Research Institute Ancillary Agreement

This Ancillary Agreement modifies the Uniform Biological Material Transfer Agreement (UBMTA) clauses I (10) and II (5.c). The modifications to these clauses are:

I (10): "Screening compound libraries" when done solely for noncommercial, teaching, and academic research, is permitted and is not considered a use of the MATERIAL or MODIFICATIONS constituting a COMMERCIAL PURPOSE.

II (5.c): The sentence "It is recognized by the RECIPIENT that such COMMERCIAL PURPOSES may require a commercial license from the PROVIDER and the PROVIDER has no obligation to grant a commercial license to its ownership and intellectual property rights in the MATERIAL incorporated in the MODIFICATIONS." has been modified from the original sentence in the UBMTA in that "ownership and intellectual property rights" has replaced "ownership interest."

With regard to any conflict between this Ancillary Agreement and the UBMTA, this Ancillary Agreement shall control and take precedence.